The biology of Hodgkin's lymphoma
- PMID: 19078975
- DOI: 10.1038/nrc2542
The biology of Hodgkin's lymphoma
Abstract
Hodgkin's lymphoma was first described in 1832. The aetiology of this lymphoma, however, remained enigmatic for a long time. Only within the past 10 years has the B-cell nature of the pathognomonic Hodgkin and Reed-Sternberg (HRS) cells been revealed, along with several recurrent genetic lesions. The pathogenetic role for Epstein-Barr virus infection has also been substantiated. HRS cells in classical Hodgkin's lymphoma have several characteristics that are unusual for lymphoid tumour cells, and the Hodgkin's lymphoma microenvironment is dominated by an extensive mixed, potentially inflammatory cellular infiltrate. Understanding the contribution of all of these changes to the pathogenesis of this disease is essential for the development of novel therapies.
Similar articles
-
Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198. J Pathol. 2013. PMID: 23592216
-
Hodgkin lymphoma.J Clin Invest. 2012 Oct;122(10):3439-47. doi: 10.1172/JCI61245. Epub 2012 Oct 1. J Clin Invest. 2012. PMID: 23023715 Free PMC article. Review.
-
Molecular biology of Hodgkin lymphoma.Hematology Am Soc Hematol Educ Program. 2009:491-6. doi: 10.1182/asheducation-2009.1.491. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008234 Review.
-
Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease.Blood. 2000 Feb 1;95(3):1023-31. Blood. 2000. PMID: 10648418
-
Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.Blood. 1999 Apr 1;93(7):2319-26. Blood. 1999. PMID: 10090942
Cited by
-
Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.Cancers (Basel). 2024 Mar 12;16(6):1126. doi: 10.3390/cancers16061126. Cancers (Basel). 2024. PMID: 38539461 Free PMC article. Review.
-
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan.Int J Hematol. 2024 Jun;119(6):667-676. doi: 10.1007/s12185-024-03734-y. Epub 2024 Mar 23. Int J Hematol. 2024. PMID: 38521840 Free PMC article.
-
Management of limited-stage Hodgkin lymphoma.Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):500-509. doi: 10.1182/hematology.2023000511. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066938
-
Potential Associations between Vascular Biology and Hodgkin's Lymphoma: An Overview.Cancers (Basel). 2023 Nov 6;15(21):5299. doi: 10.3390/cancers15215299. Cancers (Basel). 2023. PMID: 37958472 Free PMC article. Review.
-
Transcriptional reprogramming by mutated IRF4 in lymphoma.Nat Commun. 2023 Nov 7;14(1):6947. doi: 10.1038/s41467-023-41954-8. Nat Commun. 2023. PMID: 37935654 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous